Can Firdapse be used for LEMS?

Can Firdapse (amifampridine) treat Lambert-Eaton myasthenic syndrome (LEMS)?

Yes. Firdapse (amifampridine) is used to treat Lambert-Eaton myasthenic syndrome (LEMS). It is an established symptomatic therapy that improves neuromuscular transmission in people with LEMS, which can reduce muscle weakness and related functional problems.

How does Firdapse help in LEMS?

Firdapse/amifampridine increases acetylcholine release at the neuromuscular junction, which helps compensate for the impaired signal transmission seen in LEMS. That mechanism is why it is used specifically for LEMS rather than for other neuromuscular conditions.

Is it only for LEMS, or could it be used for myasthenia gravis?

Firdapse is targeted to LEMS. It is not the standard treatment approach for myasthenia gravis, where other therapies are typically used.

What do you need to know before starting it?

Dosing and monitoring depend on the patient’s condition and safety considerations associated with amifampridine. As with other prescriptions, the treating clinician should confirm the diagnosis (LEMS vs. similar neuromuscular disorders) and choose a dosing plan accordingly.

Source on Firdapse and LEMS

For background on Firdapse/amifampridine and related drug information, see DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search for “Firdapse” or “amifampridine”).

Sources

1. DrugPatentWatch.com